Investing.com - Benchmark reiterated a Buy rating and $60.00 price target on Omnicell (NASDAQ:OMCL) shares following an investor meeting with the company’s CFO. The stock has declined 15% over the ...

Omnicell recently reported Q4 2025 results that exceeded its own guidance across revenue, product bookings, and annual recurring revenue, while launching the Titan XT system to extend intelligent ...

FORT WORTH, Texas (AP) — FORT WORTH, Texas (AP) — Omnicell Inc. (OMCL) on Thursday reported a loss of $2 million in its fourth quarter. On a per-share basis, the Fort Worth, Texas-based company said ...

5 analysts have shared their evaluations of Omnicell (NASDAQ:OMCL) during the recent three months, expressing a mix of bullish and bearish perspectives. Summarizing their recent assessments, the table ...

Omnicell (OMCL) shares added ~5% on Thursday after KeyBanc Capital Markets upgraded the MedTech, citing a "super-cycle" of growth post FY26 thanks to the company's new Titan XT dispensing cabinet and ...

Powered by OmniSphere, Titan XT is built to support evolving healthcare needs while delivering greater pharmacy control and nursing confidence for a growing enterprise FORT WORTH, Texas--(BUSINESS ...

It scored not one, but two beats on analyst estimates for its third-quarter performance. This, despite a slight year-over-year decline in adjusted profitability. Revenue for Omnicell in its third ...

BRISTOL, Tenn. (WJHL) – Ballad Health held a ribbon ceremony with Omnicell to reveal three new IVX Station robots in the Central Fill Pharmacy located at the Bristol Regional Medical Center. The three ...

A month has gone by since the last earnings report for Omnicell (OMCL). Shares have added about 27% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to ...

Wells Fargo upgraded Omnicell (NASDAQ:OMCL) to Overweight from Equal Weight on Wednesday, citing a compelling risk-reward setup in the shares of the Fort Worth, Texas-based vendor of pharmacy ...